Last reviewed · How we verify

NCT02435420: HISTORIC

A Retro-prospective Study of Total Hip Arthroplasty With EMPERION Modular Primary Stem in Australian Centres (HISTORIC)

Terminated Last updated 5 February 2018
What this trial tests

trial testing EMPERION Modular Primary Stem in Osteoarthritis, Hip in 25 participants. Terminated before completion.

Timeline
1 August 2015
Primary endpoint
9 November 2017
9 November 2017

Quick facts

Lead sponsorSmith & Nephew, Inc.
StatusTerminated
Study typeOBSERVATIONAL
Enrollment25
Start date1 August 2015
Primary completion9 November 2017
Estimated completion9 November 2017
Sites8 locations across Australia

Drugs / interventions tested

Conditions studied

Sponsor

Smith & Nephew, Inc. — full company profile →

Who can join

Eligibility, any sex, with Osteoarthritis, Hip or Arthritis, Degenerative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retro-prospective, single arm, sequential enrolment study to collect relevant clinical and radiological data in at least 156 subjects, at up to 10 sites in Australia, who have been implanted with the EMPERION™ Modular Hip System in primary THA procedures to assess its safety and efficacy over 5 years post-surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Hip

Currently open trials in the same condition.

Other Smith & Nephew, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02435420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing